TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35079115

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg twice daily for 8 weeks, followed by bicalutamide 50 mg/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Bicalutamide 50 mg/day alone (after 8 weeks of observation)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combination of metformin and bicalutamide
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Metformin monotherapy
Number of subjects: 29
Study: 34096172

Group type: EXPERIMENTAL
Intervention: Patient-specific drill templates (PDT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fluoroscopy-guided freehand technique
Number of subjects: 10
Study: 32005192

Group type: EXPERIMENTAL
Intervention: Tranexamic acid 1g
Number of subjects: 4524

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4524
Study: 34922898

Group type: COMPARATOR
Intervention: Routine care (RC) diagnostic pathway (n = 393)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: Urodynamics (UDS) in addition to routine care (n = 427)
Number of subjects: 820
Study: 32770693

Group type: EXPERIMENTAL
Intervention: Single-plane MFU-V treatment (4 MHz/4.5 mm transducer)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dual-plane MFU-V treatment (4 MHz/4.5 mm and 7 MHz/3.0 mm transducer)
Number of subjects: 30
Study: 36128684

Group type: EXPERIMENTAL
Intervention: Ketamine plus active 'automated self‐association training' (ASAT)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Saline plus active ASAT
Number of subjects: 154

Group type: COMPARATOR
Intervention: Ketamine plus sham ASAT
Number of subjects: 154
Study: 33358891

Group type: EXPERIMENTAL
Intervention: Basic model (age, prostate-specific antigen, clinical T stage, biopsy GGG, percentage of positive cores)
Number of subjects: 4048

Group type: EXPERIMENTAL
Intervention: Extended model (age, prostate-specific antigen, clinical T stage, biopsy GGG, prostate volume, percentage of tumor within all biopsy cores)
Number of subjects: 4048

Group type: COMPARATOR
Intervention: NCCN IR PCa stratification
Number of subjects: 4048

Group type: EXPERIMENTAL
Intervention: Basic model
Number of subjects: 4048

Group type: EXPERIMENTAL
Intervention: Extended model
Number of subjects: 4048
Study: 37720054

Group type: EXPERIMENTAL
Intervention: Collaborative care model
Number of subjects: 528

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 528
Study: 36455988

Group type: EXPERIMENTAL
Intervention: Digital adherence technologies (DATs) based behavioural support programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Differentiated care targeting high-risk patients
Number of subjects: 0
Study: 32490686

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36049477

Group type: EXPERIMENTAL
Intervention: Raltegravir-based cART
Number of subjects: 281

Group type: COMPARATOR
Intervention: Efavirenz-based cART
Number of subjects: 281
Study: 35644803

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) with flow: 50 L/min and FIO2 of 1.0
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ordinary supplemental oxygen via a nasal cannula (flow: 6 L/min)
Number of subjects: 32
Study: 32520874

Group type: EXPERIMENTAL
Intervention: Turbine™ device
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham control condition (breathing room air)
Number of subjects: 8
Study: 36351727

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment (ciprofloxacin and metronidazole) added to surgical drainage of perianal abscess
Number of subjects: 298

Group type: COMPARATOR
Intervention: Surgical drainage alone
Number of subjects: 298
Study: 34085779

Group type: EXPERIMENTAL
Intervention: subcutaneous Ig (IgPro20; Hizentra®)
Number of subjects: 171

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 171
Study: 32785245

Group type: EXPERIMENTAL
Intervention: Acceptance Facilitating Intervention (AFI) - short video showing an example of blended therapy
Number of subjects: 284

Group type: COMPARATOR
Intervention: Control Group (CG) - attention placebo video
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Acceptance Facilitating Intervention (AFI)
Number of subjects: 284
Study: 36482813

Group type: EXPERIMENTAL
Intervention: Short Message Service + Interpersonal Communication (SMS + IPC)
Number of subjects: 1394

Group type: COMPARATOR
Intervention: Interpersonal Communication (IPC) only
Number of subjects: 1394

Group type: EXPERIMENTAL
Intervention: Other intervention groups (not specified)
Number of subjects: 1394
Study: 35235958

Group type: EXPERIMENTAL
Intervention: Late preterm ACS
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Inappropriate ACS for maternal/fetal status
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Inappropriate ACS for preterm labor
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Inappropriate ACS in preterm labor
Number of subjects: 660
Study: 34687909

Group type: EXPERIMENTAL
Intervention: Nursing navigation program (including 30-minute visual training and handbook on adverse effects, followed by phone reminders and counseling for 7 weeks)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard treatment approaches (control group)
Number of subjects: 88
Study: 33181664

Group type: EXPERIMENTAL
Intervention: Acupoint injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sacral canal injection
Number of subjects: 0
Study: 34215598

Group type: EXPERIMENTAL
Intervention: Single-layer unlocked uterine closure
Number of subjects: 2292

Group type: COMPARATOR
Intervention: Double-layer unlocked uterine closure
Number of subjects: 2292
Study: 32140879

Group type: EXPERIMENTAL
Intervention: UO/TAC (UniORV)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Crystalline TAC (control)
Number of subjects: 8
Study: 34144145

Group type: EXPERIMENTAL
Intervention: Yoga (12 weekly sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist (control group)
Number of subjects: 60
Study: 36047065

Group type: EXPERIMENTAL
Intervention: Taurine 3 g, twice/day, orally for 12 weeks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 32440731

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (1.32×10^11 CFU live bacteria including Lactobacillus acidophilus, Lactobacillus rhamnosus GG, Bifidobacterium animalis, and Bifidobacterium longum daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 40
Study: 33441352

Group type: EXPERIMENTAL
Intervention: Automated feedback intervention (OPEN Stewardship)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-participants (control group)
Number of subjects: 150
Study: 32400356

Group type: EXPERIMENTAL
Intervention: Praziquantel mass drug administration (MDA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Four annual rounds of praziquantel MDA
Number of subjects: 0

Group type: COMPARATOR
Intervention: No praziquantel MDA
Number of subjects: 0
Study: 32598751

Group type: COMPARATOR
Intervention: Triple therapy (Omeprazole 20 mg 2 times a day, Amoxicillin 1000 mg 2 times a day, Clarithromycin 500 mg 2 times a day)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Quadruple therapy with bismuth (Omeprazole 20 mg 2 times a day, Tetracycline 500 mg 4 times a day, Metronidazole 500 mg 3 times a day, Bismuth subcitrate potassium 120 mg 4 times a day)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Quadruple therapy without bismuth (Omeprazole 20 mg 2 times a day, Amoxicillin 1000 mg 2 times a day, Clarithromycin 500 mg 2 times a day, Metronidazole 500 mg 2 times a day)
Number of subjects: 210
Study: 36295622

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control (no ESPB)
Number of subjects: 83
Study: 33348047

Group type: EXPERIMENTAL
Intervention: Repetitive-anodal tDCS
Number of subjects: 54

Group type: COMPARATOR
Intervention: Repetitive-sham
Number of subjects: 54

Group type: COMPARATOR
Intervention: Interleaved-sham
Number of subjects: 54
Study: 35187781

Group type: EXPERIMENTAL
Intervention: BBL treatment and intradermal injection of BTX
Number of subjects: 22

Group type: COMPARATOR
Intervention: BBL treatment and intradermal injection of normal saline
Number of subjects: 22
Study: 34444714

Group type: EXPERIMENTAL
Intervention: Endurance training (group A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Endurance strength training (group B)
Number of subjects: 44
Study: 32660530

Group type: EXPERIMENTAL
Intervention: Endoscopic IVH evacuation surgery
Number of subjects: 956

Group type: COMPARATOR
Intervention: External ventricular drainage (EVD)
Number of subjects: 956
Study: 33857940

Group type: EXPERIMENTAL
Intervention: Endotoxin Adsorbent (EA) therapy
Number of subjects: 6
Study: 33111988

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate 2.5 mg chip (ChxC) as an adjunctive treatment to subgingival debridement
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate 2.5 mg chip (ChxC)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control group (no chlorhexidine chips)
Number of subjects: 290
Study: 36460267

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: PrEP Adherence Support Services (PASS)
Number of subjects: 526
Study: 33913745

Group type: EXPERIMENTAL
Intervention: Baby-led self-attachment breastfeeding support intervention
Number of subjects: 504

Group type: COMPARATOR
Intervention: Standard postpartum care
Number of subjects: 504
Study: 32379217

Group type: EXPERIMENTAL
Intervention: 15 mg E4
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study: 36201639

Group type: EXPERIMENTAL
Intervention: HEV-filtering contact lens
Number of subjects: 61

Group type: COMPARATOR
Intervention: Clear contact lens (control)
Number of subjects: 61
Study: 32748765

Group type: EXPERIMENTAL
Intervention: Multimodal intervention (audits, live lessons, e-learning, posters, photo contest)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Multimodal intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 66
Study: 35326333

Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 42
Study: 32294698

Group type: EXPERIMENTAL
Intervention: Passive Cycle Ergometry (PCE)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: FES with PCE
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 35788255

Group type: EXPERIMENTAL
Intervention: Ibudilast (n=20)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (n=25)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 45
Study: 34629442

Group type: EXPERIMENTAL
Intervention: Intratympanic OTO-313
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32907576

Group type: EXPERIMENTAL
Intervention: Navafenterol (50-2100 μg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 35777814

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: No ULT
Number of subjects: 119
Study: 34031023

Group type: EXPERIMENTAL
Intervention: Hypothermia (ZOLL® Proteus™ intravascular cooling system)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 111
Study: 34236413

Group type: EXPERIMENTAL
Intervention: Immediate intervention group
Number of subjects: 330

Group type: COMPARATOR
Intervention: Delayed intervention group
Number of subjects: 330
Study: 32000798

Group type: EXPERIMENTAL
Intervention: Oligohydramnios (defined as Amniotic Fluid Index < 5 cm)
Number of subjects: 12940

Group type: EXPERIMENTAL
Intervention: Oligohydramnios
Number of subjects: 12940
Study: 35043571

Group type: EXPERIMENTAL
Intervention: Alginate dressings with silver and high-G cellulose
Number of subjects: 65

Group type: COMPARATOR
Intervention: Simple gauges (Control)
Number of subjects: 65
Study: 33428906

Group type: EXPERIMENTAL
Intervention: Intervention video
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control video
Number of subjects: 225
Study: 34923618

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Invasive coronary angiography (ICA)
Number of subjects: 120
Study: 35997105

Group type: EXPERIMENTAL
Intervention: 4 units of cryoprecipitate added to routine treatments
Number of subjects: 54

Group type: COMPARATOR
Intervention: Routine treatments without cryoprecipitate
Number of subjects: 54
Study: 34766913

Group type: EXPERIMENTAL
Intervention: CORE smartphone intervention used from T1 to T2
Number of subjects: 315

Group type: COMPARATOR
Intervention: Waitlist control group (received CORE from T2 to T3)
Number of subjects: 315
Study: 32328834

Group type: EXPERIMENTAL
Intervention: Increased soluble IL-6R (s-IL-6R) levels (per 1 standard deviation)
Number of subjects: 0
Study: 34608564

Group type: EXPERIMENTAL
Intervention: Unsolicited endocrinology eConsultation
Number of subjects: 161
Study: 33621788

Group type: EXPERIMENTAL
Intervention: JAK2V617F mutation positive
Number of subjects: 3643

Group type: EXPERIMENTAL
Intervention: Myelofibrosis patients
Number of subjects: 3643

Group type: EXPERIMENTAL
Intervention: SOD2 T allele
Number of subjects: 3643
Study: 32531432

Group type: EXPERIMENTAL
Intervention: Enterovirus 71 (EV71) vaccine
Number of subjects: 50
Study: 36374629

Group type: EXPERIMENTAL
Intervention: Nail remodeling with acrylics
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nail retraining using gauze bandaging
Number of subjects: 20
Study: 33657870

Group type: EXPERIMENTAL
Intervention: DPP‐GLB
Number of subjects: 122

Group type: COMPARATOR
Intervention: FIP
Number of subjects: 122

Group type: COMPARATOR
Intervention: BBBL
Number of subjects: 122

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 122
Study: 32252094

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 40776

Group type: COMPARATOR
Intervention: Control (no scopolamine)
Number of subjects: 40776
Study: 36410776

Group type: EXPERIMENTAL
Intervention: Serious game intervention played at will during 3 months
Number of subjects: 186

Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Serious game intervention
Number of subjects: 186
Study: 32077057

Group type: EXPERIMENTAL
Intervention: Intranasal glulisine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 35944042

Group type: EXPERIMENTAL
Intervention: Community engagement intervention designed to improve the quality of healthcare and health insurance services
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 64
Study: 34696733

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided psoas compartment block (PCB) with bupivacaine 0.125% 6-8 ml/h
Number of subjects: 90

Group type: COMPARATOR
Intervention: Spinal anesthesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 90
Study: 32404742

Group type: EXPERIMENTAL
Intervention: Probiotics supplemented with 100 mg bovine lactoferrin (bLf)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Probiotics without bovine lactoferrin (bLf)
Number of subjects: 0
Study: 36274258

Group type: EXPERIMENTAL
Intervention: Low sugar claim
Number of subjects: 501

Group type: COMPARATOR
Intervention: No claim control
Number of subjects: 501
Study: 33079313

Group type: EXPERIMENTAL
Intervention: 6-item Headache Impact Test (HIT-6)
Number of subjects: 1072
Study: 35817738

Group type: EXPERIMENTAL
Intervention: HIFU and ultrasound-guided percutaneous anhydrous ethanol injection with oxytocin
Number of subjects: 60

Group type: COMPARATOR
Intervention: HIFU and ultrasound-guided percutaneous anhydrous ethanol injection (Control)
Number of subjects: 60
Study: 33906853

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg two times per day for 16 weeks
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo→Tofacitinib
Number of subjects: 269
Study: 36154509

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Intratympanic lidocaine (ITL)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD2, 5 mg/ml)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD1, 2 mg/ml)
Number of subjects: 124
Study: 32171800

Group type: EXPERIMENTAL
Intervention: 6 hours of fasting
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 6 hours of fasting followed by 1 hour of refeeding
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (fed)
Number of subjects: 3
Study: 34425422

Group type: EXPERIMENTAL
Intervention: Self-management training program (delivered by physical therapy doctoral students, 6-week duration)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Self-management training program
Number of subjects: 38
Study: 32503465

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: HIIT and MICT
Number of subjects: 100
Study: 36119666

Group type: EXPERIMENTAL
Intervention: Multiple-component and multifactorial personalized intervention
Number of subjects: 403

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 403
Study: 32672669

Group type: EXPERIMENTAL
Intervention: Netarsudil/Latanoprost FDC
Number of subjects: 750

Group type: COMPARATOR
Intervention: Netarsudil
Number of subjects: 750

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 750
Study: 35775676

Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine injection
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no bupivacaine injection)
Number of subjects: 120
Study: 33707520

Group type: EXPERIMENTAL
Intervention: Listening to music during surgery
Number of subjects: 84

Group type: COMPARATOR
Intervention: No music intervention (control group)
Number of subjects: 84
Study: 34535967

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months for 12 months
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Denosumab 180 mg every 6 months for 12 months
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Denosumab (both dosages)
Number of subjects: 82
Study: 32833167

Group type: EXPERIMENTAL
Intervention: Gatekeeper training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trainee participation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trainer engagement
Number of subjects: 0
Study: 36124755

Group type: EXPERIMENTAL
Intervention: Intensive Language‐Action Therapy combined with standard care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 60
Study: 34533295

Group type: EXPERIMENTAL
Intervention: Gamification strategy intervention
Number of subjects: 2197

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2197
Study: 33934062

Group type: EXPERIMENTAL
Intervention: 1-year PA intervention that encouraged neighborhood walking
Number of subjects: 305

Group type: COMPARATOR
Intervention: Healthy aging control condition
Number of subjects: 305
Study: 32052777

Group type: EXPERIMENTAL
Intervention: Simulated placement
Number of subjects: 29

Group type: COMPARATOR
Intervention: Traditional clinical placement
Number of subjects: 29
Study: 35451681

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) syndrome differentiation
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 34341980

Group type: EXPERIMENTAL
Intervention: EHR documentation burden
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: EHR burden
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Satisfaction with jobs
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Satisfaction with careers
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Satisfaction with lives
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Work-life balance challenges
Number of subjects: 1096
Study: 32604148

Group type: EXPERIMENTAL
Intervention: Daily Undulating Periodization (DUP)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Nonperiodized Training (NPT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 41
Study: 33852013

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (60% of total energy)
Number of subjects: 70
Study: 35319310

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 1582

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1582
Study: 34164939

Group type: EXPERIMENTAL
Intervention: Various mental health interventions including Cognitive Behaviour Therapy, psychosocial approaches, group-based and family strengthening interventions, economic empowerment combined with family strengthening, group-based mindfulness, and community interventions.
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Traditional mental health treatments and psychosocial interventions.
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Trained lay counsellors as facilitators.
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Randomized control trials and pilot studies.
Number of subjects: 13
Study: 35922093

Group type: EXPERIMENTAL
Intervention: Wet compress combined with chitosan wound dressing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wet compress
Number of subjects: 80
Study: 33482888

Group type: EXPERIMENTAL
Intervention: TESI combined with levobupivacaine added to oral pain medication
Number of subjects: 3

Group type: COMPARATOR
Intervention: Oral pain medication alone
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Transforaminal epidural injection with levobupivacaine and saline solution added to oral pain medication
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (oral pain medication alone)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 3
Study: 35435194

Group type: EXPERIMENTAL
Intervention: Dexamethasone combined with oxybuprocaine hydrochloride gel (G group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 60